Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines
- PMID: 33679384
- PMCID: PMC7926205
- DOI: 10.3389/fphar.2020.586993
Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines
Abstract
The emergence of viral pneumonia caused by a novel coronavirus (CoV), known as the 2019 novel coronavirus (2019-nCoV), resulted in a contagious acute respiratory infectious disease in December 2019 in Wuhan, Hubei Province, China. Its alarmingly quick transmission to many countries across the world and a considerable percentage of morbidity and mortality made the World Health Organization recognize it as a pandemic on March 11, 2020. The perceived risk of infection has led many research groups to study COVID-19 from different aspects. In this literature review, the phylogenetics and taxonomy of COVID-19 coronavirus, epidemiology, and respiratory viruses similar to COVID-19 and their mode of action are documented in an approach to understand the behavior of the current virus. Moreover, we suggest targeting the receptors of SARS-CoV and SARS-CoV-2 such as ACE2 and other proteins including 3CLpro and PLpro for improving antiviral activity and immune response against COVID-19 disease. Additionally, since phytochemicals play an essential role in complementary therapies for viral infections, we summarized different bioactive natural products against the mentioned respiratory viruses with a focus on influenza A, SARS-CoV, MERS, and COVID-19.Based on current literature, 130 compounds have antiviral potential, and of these, 94 metabolites demonstrated bioactivity against coronaviruses. Interestingly, these are classified in different groups of natural products, including alkaloids, flavonoids, terpenoids, and others. Most of these compounds comprise flavonoid skeletons. Based on our survey, xanthoangelol E (88), isolated from Angelica keiskei (Miq.) Koidz showed inhibitory activity against SARS-CoV PLpro with the best IC50 value of 1.2 μM. Additionally, hispidulin (3), quercetin (6), rutin (8), saikosaponin D (36), glycyrrhizin (47), and hesperetin (55) had remarkable antiviral potential against different viral infections. Among these compounds, quercetin (6) exhibited antiviral activities against influenza A, SARS-CoV, and COVID-19 and this seems to be a highly promising compound. In addition, our report discusses the obstacles and future perspectives to highlight the importance of developing screening programs to investigate potential natural medicines against COVID-19.
Keywords: 2019-nCoV; COVID-19; antiviral potential; coronavirus; epidemiology; mode of action; phylogenetic; phytochemicals.
Copyright © 2021 Omrani, Keshavarz, Nejad Ebrahimi, Mehrabi, McGaw, Ali Abdalla and Mehrbod.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.Microb Pathog. 2021 Aug;157:104933. doi: 10.1016/j.micpath.2021.104933. Epub 2021 May 11. Microb Pathog. 2021. PMID: 33984466 Free PMC article. Review.
-
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130. Curr Pharm Des. 2021. PMID: 34225607 Review.
-
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26. Drug Resist Updat. 2020. PMID: 33132205 Free PMC article. Review.
-
Effective inhibition of coronavirus replication by Polygonum cuspidatum.Front Biosci (Landmark Ed). 2021 Oct 30;26(10):789-798. doi: 10.52586/4988. Front Biosci (Landmark Ed). 2021. PMID: 34719206
-
Bioactive natural compounds against human coronaviruses: a review and perspective.Acta Pharm Sin B. 2020 Jul;10(7):1163-1174. doi: 10.1016/j.apsb.2020.06.002. Epub 2020 Jun 8. Acta Pharm Sin B. 2020. PMID: 32834947 Free PMC article. Review.
Cited by
-
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review.Clin Pharmacol. 2024 Jan 4;16:1-25. doi: 10.2147/CPAA.S429064. eCollection 2024. Clin Pharmacol. 2024. PMID: 38197085 Free PMC article. Review.
-
Highly sensitive indirect competitive enzyme-linked immunosorbent assay based on a monoclonal antibody against saikosaponin b2 for quality control of Kampo medicines containing Bupleuri radix.J Nat Med. 2024 Jan;78(1):160-168. doi: 10.1007/s11418-023-01753-3. Epub 2023 Oct 7. J Nat Med. 2024. PMID: 37804411
-
Screening potential treatments for mpox from Traditional Chinese Medicine by using a data-driven approach.Medicine (Baltimore). 2023 Sep 15;102(37):e35116. doi: 10.1097/MD.0000000000035116. Medicine (Baltimore). 2023. PMID: 37713907 Free PMC article.
-
A study on the effect of natural products against the transmission of B.1.1.529 Omicron.Virol J. 2023 Aug 25;20(1):191. doi: 10.1186/s12985-023-02160-6. Virol J. 2023. PMID: 37626376 Free PMC article. Review.
-
In-Silico Approaches for the Screening and Discovery of Broad-Spectrum Marine Natural Product Antiviral Agents Against Coronaviruses.Infect Drug Resist. 2023 Apr 19;16:2321-2338. doi: 10.2147/IDR.S395203. eCollection 2023. Infect Drug Resist. 2023. PMID: 37155475 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
